Below is a detailed analysis of the quarterly data for Archean Chemical Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
For Sales, as of Mar 2025, the value is 322.00 Cr.. The value appears strong and on an upward trend. It has increased from 243.00 Cr. (Dec 2024) to 322.00 Cr., marking an increase of 79.00 Cr..
For Expenses, as of Mar 2025, the value is 232.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 158.00 Cr. (Dec 2024) to 232.00 Cr., marking an increase of 74.00 Cr..
For Operating Profit, as of Mar 2025, the value is 90.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Dec 2024) to 90.00 Cr., marking an increase of 6.00 Cr..
For OPM %, as of Mar 2025, the value is 28.00%. The value appears to be declining and may need further review. It has decreased from 35.00% (Dec 2024) to 28.00%, marking a decrease of 7.00%.
For Other Income, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 12.00 Cr..
For Interest, as of Mar 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Dec 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
For Depreciation, as of Mar 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 19.00 Cr..
For Profit before tax, as of Mar 2025, the value is 80.00 Cr.. The value appears strong and on an upward trend. It has increased from 75.00 Cr. (Dec 2024) to 80.00 Cr., marking an increase of 5.00 Cr..
For Tax %, as of Mar 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Dec 2024) to 27.00%, marking an increase of 2.00%.
For Net Profit, as of Mar 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Dec 2024) to 58.00 Cr., marking an increase of 2.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 4.72. The value appears strong and on an upward trend. It has increased from 4.56 (Dec 2024) to 4.72, marking an increase of 0.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 2:56 pm
Metric
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
439
566
608
741
1,130
1,441
1,330
1,014
Expenses
356
497
460
478
663
807
865
691
Operating Profit
83
69
148
262
467
634
464
323
OPM %
19%
12%
24%
35%
41%
44%
35%
32%
Other Income
6
121
8
14
13
44
47
9
Interest
102
114
122
130
162
97
10
9
Depreciation
73
47
52
55
67
69
70
73
Profit before tax
-85
29
-17
90
251
513
431
250
Tax %
-7%
-41%
105%
26%
25%
25%
25%
26%
Net Profit
-79
41
-36
67
189
384
322
185
EPS in Rs
-79.16
21.31
-18.50
34.56
19.58
31.18
26.12
14.98
Dividend Payout %
0%
0%
0%
0%
0%
8%
11%
20%
×
Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
2018-2019
2019-2020
2020-2021
2021-2022
2022-2023
2023-2024
2024-2025
YoY Net Profit Growth (%)
151.90%
-187.80%
286.11%
182.09%
103.17%
-16.15%
-42.55%
Change in YoY Net Profit Growth (%)
0.00%
-339.70%
473.92%
-104.02%
-78.91%
-119.32%
-26.40%
Archean Chemical Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
Compounded Sales Growth
10 Years:
%
5 Years:
11%
3 Years:
-4%
TTM:
-24%
Compounded Profit Growth
10 Years:
%
5 Years:
52%
3 Years:
5%
TTM:
-33%
Stock Price CAGR
10 Years:
%
5 Years:
%
3 Years:
%
1 Year:
-6%
Return on Equity
10 Years:
%
5 Years:
27%
3 Years:
22%
Last Year:
12%
Last Updated: Unknown
No data available for the Balance Sheet data table.
After reviewing the key financial ratios for Archean Chemical Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
For Basic EPS (Rs.), as of Mar 25, the value is 13.13. This value is within the healthy range. It has decreased from 25.90 (Mar 24) to 13.13, marking a decrease of 12.77.
For Diluted EPS (Rs.), as of Mar 25, the value is 13.12. This value is within the healthy range. It has decreased from 25.87 (Mar 24) to 13.12, marking a decrease of 12.75.
For Cash EPS (Rs.), as of Mar 25, the value is 19.57. This value is within the healthy range. It has decreased from 31.55 (Mar 24) to 19.57, marking a decrease of 11.98.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 151.02. It has increased from 137.89 (Mar 24) to 151.02, marking an increase of 13.13.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 151.02. It has increased from 137.89 (Mar 24) to 151.02, marking an increase of 13.13.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 84.34. It has decreased from 107.79 (Mar 24) to 84.34, marking a decrease of 23.45.
For PBDIT / Share (Rs.), as of Mar 25, the value is 28.47. This value is within the healthy range. It has decreased from 41.00 (Mar 24) to 28.47, marking a decrease of 12.53.
For PBIT / Share (Rs.), as of Mar 25, the value is 22.04. This value is within the healthy range. It has decreased from 35.30 (Mar 24) to 22.04, marking a decrease of 13.26.
For PBT / Share (Rs.), as of Mar 25, the value is 18.13. This value is within the healthy range. It has decreased from 34.62 (Mar 24) to 18.13, marking a decrease of 16.49.
For Net Profit / Share (Rs.), as of Mar 25, the value is 13.14. This value is within the healthy range. It has decreased from 25.85 (Mar 24) to 13.14, marking a decrease of 12.71.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 13.14. This value is within the healthy range. It has decreased from 25.85 (Mar 24) to 13.14, marking a decrease of 12.71.
For PBDIT Margin (%), as of Mar 25, the value is 33.75. This value is within the healthy range. It has decreased from 38.04 (Mar 24) to 33.75, marking a decrease of 4.29.
For PBIT Margin (%), as of Mar 25, the value is 26.13. This value exceeds the healthy maximum of 20. It has decreased from 32.75 (Mar 24) to 26.13, marking a decrease of 6.62.
For PBT Margin (%), as of Mar 25, the value is 21.49. This value is within the healthy range. It has decreased from 32.11 (Mar 24) to 21.49, marking a decrease of 10.62.
For Net Profit Margin (%), as of Mar 25, the value is 15.57. This value exceeds the healthy maximum of 10. It has decreased from 23.98 (Mar 24) to 15.57, marking a decrease of 8.41.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 15.57. This value is within the healthy range. It has decreased from 23.98 (Mar 24) to 15.57, marking a decrease of 8.41.
For Return on Networth / Equity (%), as of Mar 25, the value is 8.69. This value is below the healthy minimum of 15. It has decreased from 18.74 (Mar 24) to 8.69, marking a decrease of 10.05.
For Return on Capital Employeed (%), as of Mar 25, the value is 12.38. This value is within the healthy range. It has decreased from 22.67 (Mar 24) to 12.38, marking a decrease of 10.29.
For Return On Assets (%), as of Mar 25, the value is 6.77. This value is within the healthy range. It has decreased from 15.51 (Mar 24) to 6.77, marking a decrease of 8.74.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 0.2. It has increased from 0.03 (Mar 24) to 0.08, marking an increase of 0.05.
For Total Debt / Equity (X), as of Mar 25, the value is 0.09. This value is within the healthy range. It has increased from 0.03 (Mar 24) to 0.09, marking an increase of 0.06.
For Asset Turnover Ratio (%), as of Mar 25, the value is 0.46. It has decreased from 0.69 (Mar 24) to 0.46, marking a decrease of 0.23.
For Current Ratio (X), as of Mar 25, the value is 3.50. This value exceeds the healthy maximum of 3. It has decreased from 5.38 (Mar 24) to 3.50, marking a decrease of 1.88.
For Quick Ratio (X), as of Mar 25, the value is 2.65. This value exceeds the healthy maximum of 2. It has decreased from 4.44 (Mar 24) to 2.65, marking a decrease of 1.79.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 4. It has increased from 0.32 (Mar 24) to 0.42, marking an increase of 0.10.
For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 17.37 (Mar 24) to 0.00, marking a decrease of 17.37.
For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 14.23 (Mar 24) to 0.00, marking a decrease of 14.23.
For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 82.63 (Mar 24) to 0.00, marking a decrease of 82.63.
For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 85.77 (Mar 24) to 0.00, marking a decrease of 85.77.
For Interest Coverage Ratio (X), as of Mar 25, the value is 43.37. This value is within the healthy range. It has decreased from 59.80 (Mar 24) to 43.37, marking a decrease of 16.43.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 25.97. This value is within the healthy range. It has decreased from 38.70 (Mar 24) to 25.97, marking a decrease of 12.73.
For Enterprise Value (Cr.), as of Mar 25, the value is 6,487.30. It has decreased from 8,283.52 (Mar 24) to 6,487.30, marking a decrease of 1,796.22.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.23. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 6.23.
For EV / EBITDA (X), as of Mar 25, the value is 18.46. This value exceeds the healthy maximum of 15. It has increased from 16.37 (Mar 24) to 18.46, marking an increase of 2.09.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.11. This value exceeds the healthy maximum of 3. It has decreased from 6.22 (Mar 24) to 6.11, marking a decrease of 0.11.
For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 82.62 (Mar 24) to 0.00, marking a decrease of 82.62.
For Price / BV (X), as of Mar 25, the value is 3.41. This value exceeds the healthy maximum of 3. It has decreased from 4.86 (Mar 24) to 3.41, marking a decrease of 1.45.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.11. This value exceeds the healthy maximum of 3. It has decreased from 6.22 (Mar 24) to 6.11, marking a decrease of 0.11.
For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of Archean Chemical Industries Ltd as of June 28, 2025 is: 535.22
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of June 28, 2025, Archean Chemical Industries Ltd is Overvalued by 15.85% compared to the current share price 636.00
Intrinsic Value of Archean Chemical Industries Ltd as of June 28, 2025 is: 452.81
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of June 28, 2025, Archean Chemical Industries Ltd is Overvalued by 28.80% compared to the current share price 636.00
Last 5 Year EPS CAGR: -15.40%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Archean Chemical Industries Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 8.69% (Industry Average ROE: 10.13%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 36.5 (Industry average Stock P/E: 505.29)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0.09
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
Archean Chemical Industries Ltd. is a Private Limited Listed company incorporated on 14/07/2009 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24298TN2009PLC072270 and registration number is 072270. Currently Company is involved in the business activities of Salt production by evaporation of sea water or other saline waters. Company's Total Operating Revenue is Rs. 1013.79 Cr. and Equity Capital is Rs. 24.69 Cr. for the Year ended 31/03/2025.
INDUSTRY
ADDRESS
CONTACT
Chemicals - Inorganic - Others
No. 2, North Crescent Road, Chennai (Madras) Tamil Nadu 600017
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Archean Chemical Industries Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
